Updated June 7, 2022 4:59 pm ET Vaccine experts advising the Food and Drug Administration endorsed Novavax Inc.’s Covid-19 vaccine, voting overwhelmingly that the shot’s benefits outweighed its risks. The…

Johnson & Johnson said Monday it planned to terminate its Covid-19 vaccine supply deal with contract manufacturer Emergent BioSolutions Inc., as both companies accused each other of breaching the agreement.…

The Food and Drug Administration limited the use of the Covid-19 vaccine from Johnson and Johnson after reviewing the risk of life-threatening blood clots. The agency said Thursday that the…

Updated Apr. 28, 2022 5:03 pm ET Investors in three Covid-19 vaccine makers on Thursday rejected shareholder proposals aimed at broadening global access to the shots. Pfizer Moderna and Johnson…

Johnson & Johnson backed off its full-year forecast of sales for its Covid-19 vaccine, citing a global surplus of doses and uncertainty over how the course of the pandemic will…

Last month, a Twitter user posted a message taking aim at Johnson & Johnson for continuing to do business in Russia after the country’s invasion of Ukraine. “Stop cooperating with…

After Covid-19, vaccine makers’ next big target is a respiratory virus that kills up to 500 children a year nationwide and has been among the leading causes of U.S. hospitalizations…

Socially conscious investors and global-health activists are turning to shareholders to press Covid-19 vaccine manufacturers Pfizer Inc., Moderna Inc. and Johnson & Johnson to make more of their shots available…

U.S. drug regulators approved a new customized, cell-based treatment for blood cancer from Johnson & Johnson that is the first such therapy in the U.S. to be developed initially in…

The Food and Drug Administration has denied a petition by short sellers to halt clinical trials of an experimental Alzheimer’s drug being developed by Cassava Sciences Inc. The two short…